Carlos E. Ruiz
Carlos E. Ruiz, M.D., Ph.D., is the Director of the Structural and Congenital Heart Disease Program at Hackensack University Medical Center and at the Joseph M. Sanzari Children’s Hospital. He is Professor of Cardiology in Pediatrics and Medicine and in May 2016 he has been elected President of the Spanish Society of Pediatric Cardiology for a 3-year term. He was born and raised in Barcelona, Spain, and completed his medical degree at the University of Barcelona. He trained at the University of Barcelona, Mayo Clinic and the University of Southern California, and in 1991 was named the Director of the Pediatric and Adult Catheterization Labs at Loma Linda University Medical Center and Children’s Hospital. In 1999 became the Chief of Pediatric Cardiology at the University of Illinois at Chicago and in 2006 he moved to New York to start a devoted Structural and Congenital Heart Disease Program at the Lenox Hill Heart and Vascular Institute. He initiated the first dedicated Fellowship program in Structural and Congenital Heart Disease in the US. In conjunction with Philips engineers, his team developed the Multi-Imaging Fusion technology to plan and guide complex Structural Heart Interventions. He is Fellow of the American College of Cardiology (FACC), European Society of Cardiology (FESC) and in 2014 was name Master of the Society of Cardiac Angiography and Interventions (MSCAI). He is an internationally renowned interventional cardiologist recognized for his pioneering work in the field of interventions for Structural Heart Disease and Congenital Heart Disease. In 1986 he was one of the pioneers of the double-balloon Mitral and Aortic valvuloplasty technique and in 1994 did the first stenting of a Patent Ductus Arteriosus in a neonate born with Hypoplastic Left Heart Syndrome. In 2001 working with Dr. Philipp Bonhoeffer participated in the early experience of transcatheter pulmonary valve replacement and both together organized the first Transcatheter Valve Symposium in 2004. In February 2005 performed a CoreValve implantation in the first CoreValve long-term survival patient, still alive today, together with Dr. Jacques Seguin, Jose Antonio Condado and Dr. Jean Claude Laborde. Dr. Ruiz is an accomplished clinician, educator and researcher with more than fifteen issued patents, who have published over 300 articles on the subject of interventional cardiology, including interventions in coronary artery disease, peripheral vascular disease, and mostly in structural and congenital heart disease. He is a Co-Editor of several interventional cardiology books and numerous chapters. He served as editorial board member of many prestigious journals including the Circulation, European Heart Journal, JACC, JACC Interventions, Journal of Cardiac Angiography and Interventions, Eurointervention, Revista Española de Cardiologia, among others.